Nuclear Medicine Market Revenue 2025 to 2034
Nuclear Medicine Market Revenue 2025 to 2034
Nuclear Medicine Market (By Product: Diagnostic Products, Therapeutic Products; By Application: Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others; By End-user: Hospitals and Clinics, Diagnostic Centers, Others) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 13.21 Bn
Forecast Year, 2034
USD 35.04 Bn
CAGR, 2025 - 2034
11.45%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global nuclear medicine market is witnessing strong growth, driven by rising demand for advanced diagnostic imaging and targeted radiotherapies. Valued at USD 13.21 billion in 2025, it is expected to reach USD 35.04 billion by 2034, growing at a CAGR of 11.45%.
Nuclear Medicine Market Size Analysis
Nuclear Medicine Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostic Products | 8.98 | 9.91 | 10.94 | 12.07 | 13.32 | 14.69 | 16.20 | 17.87 | 19.71 | 21.73 |
| Therapeutic Products | 4.23 | 4.81 | 5.47 | 6.22 | 7.07 | 8.03 | 9.11 | 10.35 | 11.74 | 13.32 |
Nuclear Medicine Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiology | 1.85 | 2.03 | 2.22 | 2.44 | 2.67 | 2.93 | 3.21 | 3.51 | 3.84 | 4.21 |
| Neurology | 1.45 | 1.60 | 1.77 | 1.95 | 2.15 | 2.37 | 2.62 | 2.88 | 3.18 | 3.50 |
| Oncology | 4.49 | 5.07 | 5.72 | 6.46 | 7.29 | 8.23 | 9.28 | 10.47 | 11.81 | 13.32 |
| Thyroid | 1.59 | 1.75 | 1.93 | 2.13 | 2.36 | 2.60 | 2.87 | 3.17 | 3.49 | 3.85 |
| Lymphoma | 1.06 | 1.19 | 1.35 | 1.52 | 1.72 | 1.94 | 2.19 | 2.48 | 2.80 | 3.15 |
| Bone Metastasis | 1.32 | 1.49 | 1.68 | 1.89 | 2.13 | 2.40 | 2.70 | 3.04 | 3.42 | 3.85 |
| Endocrine Tumor | 0.79 | 0.90 | 1.02 | 1.16 | 1.31 | 1.49 | 1.69 | 1.91 | 2.17 | 2.45 |
| Others | 0.66 | 0.69 | 0.71 | 0.73 | 0.75 | 0.76 | 0.76 | 0.75 | 0.73 | 0.70 |
Nuclear Medicine Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals and Clinics | 7.40 | 8.21 | 9.12 | 10.12 | 11.23 | 12.47 | 13.84 | 15.36 | 17.05 | 18.92 |
| Diagnostic Centers | 4.49 | 5.07 | 5.72 | 6.46 | 7.29 | 8.23 | 9.28 | 10.47 | 11.81 | 13.32 |
| Others | 1.32 | 1.44 | 1.57 | 1.71 | 1.86 | 2.02 | 2.19 | 2.38 | 2.59 | 2.80 |
Nuclear Medicine Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 5.42 | 5.99 | 6.62 | 7.31 | 8.08 | 8.93 | 9.87 | 10.91 | 12.05 | 13.32 |
| Europe | 3.57 | 3.94 | 4.36 | 4.82 | 5.32 | 5.88 | 6.50 | 7.18 | 7.93 | 8.76 |
| Asia Pacific | 2.91 | 3.32 | 3.79 | 4.33 | 4.94 | 5.63 | 6.41 | 7.30 | 8.32 | 9.46 |
| Latin America | 0.79 | 0.88 | 0.98 | 1.10 | 1.22 | 1.36 | 1.52 | 1.69 | 1.89 | 2.10 |
| Middle East and Africa | 0.53 | 0.59 | 0.66 | 0.73 | 0.82 | 0.91 | 1.01 | 1.13 | 1.26 | 1.40 |
Nuclear Medicine Market Size to Reach USD 35.04 Billion by 2034
The global nuclear medicine market size is estimated at USD 13.21 billion in 2025 and is projected to be worth around USD 35.04 billion by 2034 with a CAGR of 11.45%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
